---

1) PROTEUS (mainly Proteus mirabilis, P. vulgaris)

1. Classification

• Family: Enterobacteriaceae
• Gram-negative bacilli
• Important species:
  • P. mirabilis: indole negative, common in UTI
  • P. vulgaris: indole positive

2. Morphology & Basic Features

• Gram-negative, motile, non-lactose fermenting rod
• Motility due to peritrichous flagella
• Characteristic: swarming motility on solid media
• Urease positive (very important)
• Oxidase negative

3. Culture & Biochemical Reactions

• On blood agar: concentric spreading growth (swarming)
• On MacConkey: pale colonies (non-lactose fermenter)
• Key biochemical points:
  • Urease positive
  • Phenylalanine deaminase positive (important Enterobacteriaceae differentiator)
  • H2S production often positive
  • Indole:
    • P. mirabilis negative
    • P. vulgaris positive

4. Virulence Factors

• Urease: splits urea to ammonia → alkaline urine
• Flagella: ascent in urinary tract
• Fimbriae/adhesins: adherence to uroepithelium
• Endotoxin (LPS)

5. Clinical Importance

• UTI (especially complicated/catheter-associated)
• Struvite stone formation (triple phosphate: magnesium ammonium phosphate)
• Pyelonephritis
• Wound infections, septicemia (less common)

6. Pathogenesis of Stone Formation (very high yield)

1. Urease hydrolyzes urea → ammonia
2. Urine pH rises (alkaline)
3. Precipitation of magnesium ammonium phosphate
4. Staghorn calculi may form

7. Lab Diagnosis

• Urine sample culture
• Swarming growth + urease positivity suggestive
• Species ID by biochemical tests/automated methods
• AST mandatory due to resistance patterns

8. Treatment

• Guided by sensitivity:
  • Common options: beta-lactams, aminoglycosides, fluoroquinolones, cotrimoxazole (depending on local resistance)
• In stone disease: treat infection + remove stone if needed

9. Exam Pearls

• Most likely organism with swarming growth + urease + alkaline urine: Proteus
• UTI + staghorn calculus = Proteus until proven otherwise
• Proteus is non-lactose fermenter

---

2) CLOSTRIDIUM (major exam species: C. perfringens, C. tetani, C. botulinum, C. difficile)

A. General Features of Clostridia

• Gram-positive, anaerobic, spore-forming bacilli
• Spores usually survive harsh conditions
• Toxin-mediated diseases are key

---

B. Clostridium perfringens

Key Features

• Large Gram+ “boxcar” bacilli
• Non-motile (most strains)
• Produces many toxins; major = alpha toxin (lecithinase/phospholipase C)

Diseases

• Gas gangrene (clostridial myonecrosis)
• Food poisoning (late-onset watery diarrhea)
• Cellulitis, necrotizing infection

Lab Clues

• Double zone hemolysis on blood agar
• Nagler reaction positive (lecithinase activity on egg yolk agar)
• Stormy fermentation in milk

Treatment

• Early aggressive debridement
• Penicillin + clindamycin (common classical regimen)
• Hyperbaric oxygen in selected cases

---

C. Clostridium tetani

Toxin & Pathogenesis

• Toxin: Tetanospasmin (A-B neurotoxin)
• Blocks inhibitory neurotransmitter release (GABA, glycine) in CNS
• Leads to disinhibition and muscle spasm

Clinical Features

• Trismus (lockjaw)
• Risus sardonicus
• Opisthotonus
• Painful spasms, autonomic instability

Diagnosis

• Mainly clinical
• Culture often not helpful for management decision

Management

1. Wound debridement
2. Human tetanus immunoglobulin (HTIG)
3. Metronidazole (or penicillin in some protocols)
4. Control spasms (benzodiazepines etc.)
5. Airway/ICU care
6. Active immunization with toxoid (disease does not confer reliable immunity)

Prevention

• DPT/Td/Tdap schedule + boosters
• Proper wound prophylaxis algorithm (vaccine ± TIG based on immunization status + wound type)

---

D. Clostridium botulinum

Toxin

• Botulinum toxin blocks acetylcholine release at neuromuscular junction
• Causes descending flaccid paralysis

Types

• Food-borne botulism
• Infant botulism (honey association)
• Wound botulism
• Iatrogenic

Clinical Features

• Diplopia, dysarthria, dysphagia, dry mouth
• Descending symmetrical weakness
• Constipation common in infant botulism

Treatment

• Supportive care + respiratory support
• Antitoxin early
• Avoid aminoglycosides (can worsen blockade)

---

E. Clostridioides difficile (formerly Clostridium difficile)

Disease

• Antibiotic-associated diarrhea
• Pseudomembranous colitis
• Fulminant colitis, toxic megacolon

Toxins

• Toxin A (enterotoxin), toxin B (cytotoxin)

Diagnosis

• Stool toxin assay / NAAT in correct clinical context

Treatment (current broad concept)

• Stop inciting antibiotic if possible
• Oral vancomycin or fidaxomicin (depending on setting/guidelines)
• Recurrent disease: prolonged taper/pulsed regimen, fecal microbiota approaches in selected recurrent cases

Infection Control

• Spores resistant; handwashing with soap + contact precautions important

---

Clostridium Exam Pearls

• Gas gangrene: C. perfringens
• Spastic paralysis: tetanus
• Flaccid descending paralysis: botulism
• Antibiotic-associated pseudomembranous colitis: C. difficile

---

3) TREPONEMA PALLIDUM (Syphilis)

1. Basic Microbiology

• Thin, spiral spirochete
• Too thin for standard Gram stain
• Seen by dark-field microscopy (from lesions, where available)
• Cannot be cultured in routine artificial media

2. Transmission

• Sexual contact
• Vertical (transplacental) → congenital syphilis
• Rarely blood exposure

3. Stages of Syphilis

Primary

• Painless hard chancre
• Non-tender regional lymphadenopathy

Secondary

• Disseminated stage
• Fever, malaise, generalized LAD
• Rash including palms/soles
• Condyloma lata, mucous patches

Latent

• Early latent, late latent (asymptomatic seroreactivity)

Tertiary

• Gummatous syphilis
• Cardiovascular syphilis (aortitis, aneurysm)
• Neurosyphilis (tabes dorsalis, general paresis etc.)

4. Congenital Syphilis

• Early: snuffles, rash, hepatosplenomegaly
• Late stigmata:
  • Hutchinson teeth
  • Interstitial keratitis
  • CN VIII deafness
  • Saddle nose, saber shins

5. Laboratory Diagnosis (very high yield)

Non-treponemal tests (screen + monitor)

• VDRL, RPR
• Measure disease activity (titers)
• Can become negative after treatment
• Biological false positives possible
• Prozone phenomenon can occur

Treponemal tests (confirmatory)

• TPHA, FTA-ABS, TPPA
• More specific
• Usually remain positive long-term

Neurosyphilis

• CSF VDRL is specific (not very sensitive)
• CSF analysis supportive

6. Treatment

• Penicillin is drug of choice
• Benzathine penicillin for early syphilis (stage-specific regimens)
• Neurosyphilis: aqueous crystalline penicillin G IV regimen
• Penicillin allergy in pregnancy: desensitization preferred (because penicillin best validated)

7. Important Reactions

• Jarisch-Herxheimer reaction after therapy initiation (acute febrile reaction due to spirochete lysis)

8. FMGE/NEET-PG Pearls

• Painless chancre = primary syphilis
• Palms/soles rash = secondary syphilis clue
• VDRL for monitoring response (titer fall)

---

4) SALMONELLA (Typhoidal + Non-typhoidal)

1. Classification

• Gram-negative motile bacilli, Enterobacteriaceae
• Non-lactose fermenting
• Produce H2S
• Main clinical groups:
  • Typhoidal: S. Typhi, S. Paratyphi
  • Non-typhoidal: gastroenteritis, bacteremia in risk groups

2. Antigenic Structure

• O antigen (somatic)
• H antigen (flagellar)
• Vi antigen (capsular, especially S. Typhi)

3. Typhoid Fever Pathogenesis

1. Ingestion via contaminated food/water
2. Intestinal invasion (Peyer’s patches/M cells)
3. Survival in macrophages
4. Reticuloendothelial spread
5. Bacteremia and systemic illness

4. Clinical Features of Enteric Fever

• Step-ladder fever (classical description)
• Headache, abdominal pain
• Relative bradycardia (classically described)
• Hepatosplenomegaly
• Rose spots (not always seen)
• Intestinal hemorrhage/perforation (late severe complication)

5. Lab Diagnosis

Blood culture

• Best in 1st week (high yield)

Bone marrow culture

• Most sensitive, even after antibiotics

Stool/urine culture

• More useful later weeks

Serology

• Widal: limited due to baseline titers/cross-reaction; interpret cautiously with paired samples or local baseline

Molecular/rapid tests

• Used depending on availability

6. Carrier State

• Chronic carrier: persistent excretion >1 year
• Gallbladder colonization; associated with gallstones
• Public health significance (food handlers)

7. Treatment

• Based on local resistance:
  • Ceftriaxone, azithromycin, or others as per AST and region
• XDR strains are important in some geographies

8. Prevention

• Safe water, sanitation, hygiene
• Vaccination:
  • Vi polysaccharide
  • Typhoid conjugate vaccines (in many programs)

9. Exam Pearls

• 1st week: blood culture best
• Best sensitivity overall: bone marrow culture
• Peyer’s patch ulceration complication: intestinal perforation

---

5) MYCOBACTERIUM TUBERCULOSIS

1. Microbiology

• Slender acid-fast bacillus
• Obligate aerobe
• Slow-growing; high lipid cell wall (mycolic acids)
• Cord factor, sulfatides contribute virulence

2. Staining & Culture

• Ziehl-Neelsen stain (acid-fast)
• Auramine-rhodamine fluorescent stain
• Culture:
  • Lowenstein-Jensen medium (slow, rough buff colonies)
  • Liquid culture systems are faster
• Niacin positive, nitrate reduction positive (classical lab points)

3. Pathogenesis

• Inhalation → alveolar macrophages
• Granuloma formation (Th1-mediated immunity)
• Caseous necrosis
• Latent vs active disease

4. Types of TB

• Primary TB
• Post-primary (secondary/reactivation) TB
• Extrapulmonary TB (lymph node, pleura, CNS, spine, abdomen, GU etc.)
• Miliary TB

5. Clinical Features (Pulmonary)

• Cough >2 weeks
• Fever, weight loss, night sweats
• Hemoptysis (in some cases)

6. Diagnosis (high-yield modern approach)

• Sputum AFB smear
• NAAT/CBNAAT (GeneXpert): detects MTB + rifampicin resistance
• Culture + drug susceptibility testing
• Chest imaging supportive
• TST/IGRA for latent infection support (not stand-alone active disease diagnosis)

7. Drug-Resistant TB Terms

• MDR-TB: resistant to at least isoniazid + rifampicin
• XDR-TB: broader resistance pattern (definition updated by WHO, includes MDR/RR plus additional group resistance)

8. Anti-TB Drugs

First-line

• Isoniazid (H)
• Rifampicin (R)
• Pyrazinamide (Z)
• Ethambutol (E)
• (Streptomycin historically first-line in old regimens)

Major adverse effects (very high-yield)

• H: hepatitis, peripheral neuropathy (give pyridoxine)
• R: orange body fluids, hepatitis, CYP induction
• Z: hepatotoxicity, hyperuricemia
• E: optic neuritis (red-green color vision defect)
• S: ototoxicity, nephrotoxicity

9. Treatment Principles

• Combination therapy
• Adherence critical (DOT strategies/public health programs)
• Regimen depends on drug sensitivity and national guidelines
• Monitor clinical, microbiologic, and adverse effect profile

10. BCG Vaccine

• Live attenuated M. bovis
• Mainly protects children against severe disseminated TB/meningitis forms
• Scar formation common

11. Exam Pearls

• Most infective case: smear-positive pulmonary TB
• GeneXpert detects rifampicin resistance rapidly
• Ghon focus/complex concepts asked in pathology-integrated questions

---

6) LISTERIA MONOCYTOGENES

1. Basic Features

• Gram-positive coccobacillus
• Facultative intracellular
• Motile at room temperature (“tumbling motility”)
• Beta-hemolytic
• Catalase positive
• Can grow at low temperatures (cold enrichment)

2. Reservoir & Transmission

• Food-borne: unpasteurized dairy, soft cheese, deli meats, contaminated food
• Vertical transmission (transplacental/peripartum)

3. High-Risk Groups

• Pregnant women
• Neonates
• Elderly
• Immunocompromised (transplant, malignancy, steroid use, HIV)

4. Pathogenesis

• Internalins promote host cell entry
• Listeriolysin O helps phagosomal escape
• Actin-based intracellular movement via ActA
• Cell-to-cell spread avoids antibodies

5. Clinical Manifestations

• Pregnant woman: flu-like illness/bacteremia
• Fetus/neonate: sepsis, meningitis, granulomatosis infantiseptica
• Adults (risk groups): bacteremia, meningitis/meningoencephalitis

6. Diagnosis

• Blood/CSF culture
• CSF in meningitis may show mononuclear predominance sometimes
• Gram stain may show small Gram+ rods/coccobacilli

7. Treatment

• Ampicillin (often + gentamicin in severe disease)
• Alternative in allergy: TMP-SMX (context dependent)

8. Crucial Exam Pearl

• In neonatal/elderly meningitis, Listeria coverage needed
• Cephalosporins do NOT reliably cover Listeria
  • So empiric meningitis regimens in certain age/risk groups include ampicillin

---

Rapid Comparison Table (Super High Yield)

---

1. One-page last-minute revision sheet,
2. PYQ-style MCQs (50–100) with explanations, or
3. Organism-wise mnemonics for rapid recall.